SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-110485
Filing Date
2024-09-30
Accepted
2024-09-30 19:12:50
Documents
2
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3316
2 EX-24 vrdn-ex24.htm EX-24 11122
  Complete submission text file 0000950170-24-110485.txt   16253
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Beetham Thomas W. (Reporting) CIK: 0001741382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 241340882